James Hambro & Partners increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.9% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 150,263 shares of the healthcare conglomerate’s stock after purchasing an additional 12,328 shares during the quarter. UnitedHealth Group accounts for 5.2% of James Hambro & Partners’ holdings, making the stock its 9th biggest position. James Hambro & Partners’ holdings in UnitedHealth Group were worth $55,971,000 as of its most recent SEC filing.
Several other institutional investors also recently added to or reduced their stakes in UNH. FMR LLC boosted its position in UnitedHealth Group by 0.6% during the 4th quarter. FMR LLC now owns 52,565,986 shares of the healthcare conglomerate’s stock worth $18,433,841,000 after acquiring an additional 295,642 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in UnitedHealth Group by 5.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 38,003,233 shares of the healthcare conglomerate’s stock valued at $13,318,678,000 after buying an additional 1,881,407 shares during the last quarter. Alliancebernstein L.P. grew its holdings in shares of UnitedHealth Group by 5.2% in the 4th quarter. Alliancebernstein L.P. now owns 11,485,225 shares of the healthcare conglomerate’s stock valued at $4,027,639,000 after acquiring an additional 569,142 shares in the last quarter. Norges Bank acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $3,397,896,000. Finally, Bank of New York Mellon Corp raised its stake in shares of UnitedHealth Group by 2.4% during the 4th quarter. Bank of New York Mellon Corp now owns 8,858,179 shares of the healthcare conglomerate’s stock worth $3,106,385,000 after purchasing an additional 207,865 shares in the last quarter. Institutional investors own 86.03% of the company’s stock.
Shares of UNH stock opened at $404.17 on Tuesday. The stock has a market cap of $381.49 billion, a price-to-earnings ratio of 23.31, a PEG ratio of 1.55 and a beta of 0.74. UnitedHealth Group Incorporated has a twelve month low of $273.71 and a twelve month high of $406.77. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.59. The company’s 50-day moving average price is $378.48 and its 200-day moving average price is $349.25.
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 23rd. Investors of record on Monday, March 15th were paid a dividend of $1.25 per share. The ex-dividend date was Friday, March 12th. This represents a $5.00 annualized dividend and a yield of 1.24%. UnitedHealth Group’s dividend payout ratio is currently 33.09%.
In other news, CAO Thomas E. Roos sold 5,301 shares of the firm’s stock in a transaction that occurred on Tuesday, April 27th. The stock was sold at an average price of $394.66, for a total value of $2,092,092.66. Following the completion of the sale, the chief accounting officer now directly owns 58,589 shares of the company’s stock, valued at approximately $23,122,734.74. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Thomas E. Roos sold 619 shares of the stock in a transaction dated Tuesday, February 9th. The shares were sold at an average price of $323.90, for a total transaction of $200,494.10. Following the completion of the transaction, the chief accounting officer now owns 31,908 shares of the company’s stock, valued at approximately $10,335,001.20. The disclosure for this sale can be found here. Over the last three months, insiders sold 20,420 shares of company stock valued at $7,532,962. Insiders own 0.80% of the company’s stock.
Several equities research analysts recently issued reports on UNH shares. Barclays raised their target price on shares of UnitedHealth Group from $405.00 to $435.00 and gave the company an “overweight” rating in a research note on Thursday, April 22nd. Truist Securities increased their price objective on shares of UnitedHealth Group from $420.00 to $450.00 and gave the company a “buy” rating in a research report on Tuesday, April 20th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of UnitedHealth Group from $409.00 to $418.00 and gave the stock a “buy” rating in a research report on Thursday, April 22nd. Stephens upped their price objective on UnitedHealth Group from $415.00 to $425.00 and gave the company an “overweight” rating in a report on Thursday, April 22nd. Finally, Morgan Stanley raised their price target on shares of UnitedHealth Group from $462.00 to $515.00 and gave the stock an “overweight” rating in a research report on Thursday, April 22nd. Three equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $409.61.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.
Featured Story: What is the Rule of 72?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.